The PTH Receptorsome and Transduction Pathways

  • Thomas J. GardellaEmail author


The parathyroid hormone receptor (PTHR1) mediates the actions of PTH in bone and kidney cells. The PTHR1 is a seven transmembrane domain-containing, G protein-coupled receptor (GPCR) and is a member of the “family B” subgroup of GPCRs that bind peptide hormones. PTH interacts with the PTHR1 via a “two-site” mechanism, by which the C-terminal portion of the bioactive PTH(1–34) peptide interacts with the amino-terminal extracellular domain (ECD) of the PTHR1 to establish binding affinity and the N-terminal portion of the ligand interacts with the transmembrane domain (TMD) region of the receptor to induce receptor activation and signal transduction. The activated PTHR1 couples strongly to the cAMP/PKA signaling pathway, but can also couple to other pathways, including the PLC/IP3/PKC and ERK-1/2 pathways. The activated PTHR1 is rapidly phosphorylated on its C-terminal tail and then internalizes via a β-arrestin-mediated mechanism leading to signal termination. Novel PTH ligands have been developed, however, that mediate prolonged signaling, possibly from an internalized endosomal domain. Such PTH analogs may offer new approaches for treating hypoparathyroidism.


Parathyroid hormone Receptor interactions Two-site binding mechanism Ligand binding GPCR structure 


  1. 1.
    Guo J, Liu M, Yang D et al (2010) Phospholipase C signaling via the parathyroid hormone (PTH)/PTH-related peptide receptor is essential for normal bone responses to PTH. Endocrinology 151:3502–13Google Scholar
  2. 2.
    Singh AT, Gilchrist A, Voyno-Yasenetskaya T et al (2005) G{alpha}12/G{alpha}13 subunits of heterotrimeric G proteins mediate parathyroid hormone activation of phospholipase D in UMR-106 osteoblastic cells. Endocrinology 146:2171–5Google Scholar
  3. 3.
    Luttrell LM (2014) Minireview: more than just a hammer: ligand ‘bias’ and pharmaceutical discovery. Mol Endocrinol 28(3):281–94. me.20131314CrossRefPubMedGoogle Scholar
  4. 4.
    Goldman ME, McKee RL, Caulfield MP et al (1988) A new highly potent parathyroid hormone antagonist: [d-Trp12,Tyr34]bPTH(7-34)NH2. Endocrinology 123:2597–9Google Scholar
  5. 5.
    Nussbaum SR, Rosenblatt M, Potts JT Jr (1980) Parathyroid hormone/renal receptor interactions: demonstration of two receptor-binding domains. J Biol Chem 255:10183–7PubMedGoogle Scholar
  6. 6.
    Shimizu N, Dean T, Khatri A et al (2004) Amino-terminal parathyroid hormone fragment analogs containing alpha, alpha-dialkyl amino acids at positions 1 and 3. J Bone Mineral Res 19:2078–86Google Scholar
  7. 7.
    Suva LJ, Winslow GA, Wettenhall RE et al (1987) A parathyroid hormone-related protein implicated in malignant hypercalcemia: cloning and expression. Science 237:893–6CrossRefPubMedGoogle Scholar
  8. 8.
    Pioszak AA, Parker NR, Gardella TJ et al (2009) Structural basis for parathyroid hormone-related protein binding to the parathyroid hormone receptor and design of conformation-selective peptides. J Biol Chem 284:28382–91CrossRefPubMedCentralPubMedGoogle Scholar
  9. 9.
    Jüppner H, Abou-Samra A-B, Freeman M et al (1991) A G protein-linked receptor for parathyroid hormone and parathyroid hormone-related peptide. Science 254:1024–6Google Scholar
  10. 10.
    Barwell J, Gingell JJ, Watkins HA et al (2012) Calcitonin and calcitonin receptor-like receptors: common themes with family B GPCRs? Br J Pharmacol 166:51–65Google Scholar
  11. 11.
    Hoare S, Usdin T (2001) Molecular mechanisms of ligand-recognition by parathyroid hormone 1 (PTH1) and PTH2 receptors. Curr Pharm Des 7:689–713Google Scholar
  12. 12.
    Gensure RC, Gardella TJ, Juppner H (2005) Parathyroid hormone and parathyroid hormone-related peptide, and their receptors. Biochem Biophys Res Commun 328:666–78CrossRefPubMedGoogle Scholar
  13. 13.
    Wittelsberger A, Corich M, Thomas BE et al (2006) The mid-region of parathyroid hormone (1–34) serves as a functional docking domain in receptor activation. Biochemistry 45:2027–34CrossRefPubMedGoogle Scholar
  14. 14.
    Dong M, Koole C, Wootten D et al (2014) Structural and functional insights into the juxtamembranous amino-terminal tail and extracellular loop regions of class B GPCRs. Br J Pharmacol 171:1085–101Google Scholar
  15. 15.
    Pioszak AA, Parker NR, Suino-Powell K et al (2008) Molecular recognition of corticotropin-releasing factor by its G protein-coupled receptor CRFR1. J Biol Chem 283:32900–12Google Scholar
  16. 16.
    Pioszak AA, Xu HE (2008) Molecular recognition of parathyroid hormone by its G protein-coupled receptor. Proc Natl Acad Sci U S A 105:5034–9Google Scholar
  17. 17.
    Hollenstein K, de Graaf C, Bortolato A et al (2014) Insights into the structure of class B GPCRs. Trends Pharmacol Sci 35:1Google Scholar
  18. 18.
    Dean T, Khatri A, Potetinova Z et al (2006) Role of amino acid side chains in the (17–31) domain of parathyroid hormone in binding to the PTH receptor. J Biol Chem 281:32485–95Google Scholar
  19. 19.
    Dean T, Vilardaga JP, Potts JT Jr et al (2008) Altered selectivity of parathyroid hormone (PTH) and PTH-related protein (PTHrP) for distinct conformations of the PTH/PTHrP receptor. Mol Endocrinol 22:156–66Google Scholar
  20. 20.
    Ferrandon S, Feinstein TN, Castro M et al (2009) Sustained cyclic amp production by parathyroid hormone receptor endocytosis. Nat Chem Biol 5:734–42CrossRefPubMedCentralPubMedGoogle Scholar
  21. 21.
    Horwitz MJ, Tedesco MB, Sereika SM et al (2003) Direct comparison of sustained infusion of human parathyroid hormone-related protein-(1–36) [hPTHrP-(1–36)] versus hPTH-(1–34) on serum calcium, plasma 1,25-dihydroxyvitamin D concentrations, and fractional calcium excretion in healthy human volunteers. J Clin Endocrinol Metab 88:1603–9Google Scholar
  22. 22.
    Granier S, Kobilka B (2012) A new era of GPCR structural and chemical biology. Nat Chem Biol 8:670–3Google Scholar
  23. 23.
    Coin I, Katritch V, Sun T et al (2013) Genetically encoded chemical probes in cells reveal the binding path of urocortin-1 to CRF class B GPCR. Cell 155:1258–69Google Scholar
  24. 24.
    Tsomaia N, Pellegrini M, Hyde K et al (2004) Toward parathyroid hormone minimization: conformational studies of cyclic PTH(1–14) analogues. Biochemistry 43:690–9Google Scholar
  25. 25.
    Behar V, Bisello A, Bitan G et al (2000) Photoaffinity cross-linking identifies differences in the interactions of an agonist and an antagonist with the parathyroid hormone/parathyroid hormone-related protein receptor. J Biol Chem 275:9–17CrossRefPubMedGoogle Scholar
  26. 26.
    Gensure R, Carter P, Petroni B et al (2001) Identification of determinants of inverse agonism in a constitutively active parathyroid hormone/parathyroid hormone related peptide receptor by photoaffinity cross linking and mutational analysis. J Biol Chem 276:42692–9CrossRefPubMedGoogle Scholar
  27. 27.
    Vilardaga J, Frank M, Krasel C et al (2001) Differential conformational requirements for activation of G proteins and regulatory proteins, arrestin and GRK in the G protein coupled receptor for parathyroid hormone (PTH)/PTH-related protein. J Biol Chem 31:31Google Scholar
  28. 28.
    Calvi L, Schipani E (2000) The PTH/PTHrP receptor in jansen’s metaphyseal chondrodysplasia. J Endocrinol Invest 23:545–54Google Scholar
  29. 29.
    Huang Z, Chen Y, Pratt S et al (1996) The N-terminal region of the third intracellular loop of the parathyroid hormone (PTH)/PTH-related peptide receptor is critical for coupling to camp and inositol phosphate/Ca++ signal transduction pathways. J Biol Chem 271:33382–9Google Scholar
  30. 30.
    Malecz N, Bambino T, Bencsik M et al (1998) Identification of phosphorylation sites in the G protein-coupled receptor for parathyroid hormone. Receptor phosphorylation is not required for agonist-induced internalization. Mol Endocrinol 12:1846–56Google Scholar
  31. 31.
    Rey A, Manen D, Rizzoli R et al (2006) Proline-rich motifs in the parathyroid hormone (PTH)/PTH-related protein receptor C-terminus mediate scaffolding of c-src with beta-arrestin2 for erk1/2 activation. J Biol Chem 281:38181–8Google Scholar
  32. 32.
    Maeda A, Okazaki M, Baron DM et al (2013) Critical role of parathyroid hormone (PTH) receptor-1 phosphorylation in regulating acute responses to PTH. Proc Natl Acad Sci U S A 110:5864–9Google Scholar
  33. 33.
    Sneddon WB, Friedman PA (2007) Beta-arrestin-dependent parathyroid hormone-stimulated extracellular signal-regulated kinase activation and parathyroid hormone type 1 receptor internalization. Endocrinology 148:4073–9CrossRefPubMedGoogle Scholar
  34. 34.
    Mahon M, Donowitz M, Yun C et al (2002) Na(+)/H(+) exchanger regulatory factor 2 directs parathyroid hormone 1 receptor signalling. Nature 417:858–61Google Scholar
  35. 35.
    Mamonova T, Kurnikova M, Friedman PA (2012) Structural basis for NHERF1 pdz domain binding. Biochemistry 51:3110–20Google Scholar
  36. 36.
    Ardura JA, Wang B, Watkins SC et al (2011) Dynamic Na-H+ exchanger regulatory factor-1 association and dissociation regulate parathyroid hormone receptor trafficking at membrane microdomains. J Biol Chem 286:35020–9Google Scholar
  37. 37.
    Dean T, Linglart A, Mahon MJ et al (2006) Mechanisms of ligand binding to the PTH/PTHrP receptor: selectivity of a modified pth(1–15) radioligand for g{alpha}s-coupled receptor conformations. Mol Endocrinol 20:931–42Google Scholar
  38. 38.
    Vilardaga JP, Gardella TJ, Wehbi VL et al (2012) Non-canonical signaling of the PTH receptor. Trends Pharmacol Sci 33:423–31Google Scholar
  39. 39.
    Okazaki M, Ferrandon S, Vilardaga JP et al (2008) Prolonged signaling at the parathyroid hormone receptor by peptide ligands targeted to a specific receptor conformation. Proc Natl Acad Sci U S A 105:16525–30CrossRefPubMedCentralPubMedGoogle Scholar
  40. 40.
    Shimizu M, Ichikawa F, Noda H et al (2008) A new long-acting PTH/PTHrP hybrid analog that binds to a distinct PTHR conformation has superior efficacy in a rat model of hypoparathyroidism. J Bone Mineral Res 23(S1):S128 (Abstract)Google Scholar

Copyright information

© Springer-Verlag Italia 2015

Authors and Affiliations

  1. 1.Endocrine UnitMassachusetts General Hospital, Harvard Medical SchoolBostonUSA

Personalised recommendations